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Objectives To investigate the genetic environment of the metallo-β-lactamase gene blaNDM-1 in an 
Acinetobacter baumannii isolated in 2007 in a German hospital.  
Methods Antimicrobial susceptibility testing was performed and resistance genes were characterized 
by PCR amplification and sequencing. Transferability of β-lactam resistance was tested by broth 
mating assays and transformation of plasmids. The genetic background of blaNDM-1 was analysed by 
primer walking. Typing of the A. baumannii strain was performed by repetitive extragenic palindromic 
sequence-based PCR (rep-PCR) using the DiversiLab system.  
Results The multidrug-resistant A. baumannii isolate harboured β-lactamase genes blaNDM-1 and 
intrinsic blaOXA-64, but without the insertion sequence ISAba1 often located upstream. Transfer of 
carbapenem resistance by conjugation and transformation failed. Hybridization of isolated plasmid 
DNA with blaNDM probes was not successful. Shotgun cloning of whole genomic DNA and sequence 
analyses revealed that blaNDM-1 was located between two insertion elements of ISAba125. 
Furthermore, this blaNDM-1-containing transposon structure was integrated into a chromosomal gene 
encoding a putative A. baumannii major facilitator superfamily (MFS) metabolite/H
+
 symporter.  
Conclusions The metallo-β-lactamase gene blaNDM-1 in this A. baumannii strain was integrated in the 
chromosome on a new transposon structure composed of two copies of insertion sequence ISAba125. 
The variability of the genetic environment of blaNDM-1 likely facilitates the rapid dissemination of this 
gene within many Gram-negative bacterial species.  
 
Introduction 
In recent years an increasing number of reports on the emergence of multidrug-resistant Gram-
negative pathogens have been published and in particular it is the emergence of blaNDM-1 that has 
created the most concern.
1,2
 Indeed, since its first description in 2009, this metallo-β-lactamase (MBL) 
has now been found worldwide.
3,4
 NDM-1 has been identified in various Enterobacteriaceae due to 
localization of blaNDM-1 on conjugative plasmids, enabling transfer and rapid dissemination of multidrug 
resistance.
4
 In 2010 blaNDM-1 and the related blaNDM-2 gene were also found in Acinetobacter 
baumannii, whereby either plasmid transfer of these genes was confirmed or the genetic location was 
not further investigated in detail.
5–8
 Infections with carbapenemase-producing A. baumannii are a 
serious threat because colistin is often the only treatment option. Carbapenem resistance in A. 
baumannii is mainly due to expression of various OXA β-lactamases, such as OXA-23, OXA-58, OXA-
40 and OXA-143-related enzymes, as well as overexpression of the intrinsic OXA-51-like enzyme.
9
 
Non-OXA-mediated carbapenem resistance is still rare. Here we report the molecular characterization 
  
of the genetic environment of blaNDM-1 detected in a clinical A. baumannii strain from a German 
hospital.  
 
Materials and methods 
Bacterial strains 
A. baumannii strain 161/07 was isolated from a patient who had been repatriated to Germany from 
Serbia in 2007. The case history surrounding this blaNDM-1-positive A. baumannii strain 161/07 has 
been described previously.
6
 Standard A. baumannii ATCC 19606 and ATCC 17978 were used as 
recipients for plasmid transformation. Sodium azide-resistant Escherichia coli J53 was used as the 
recipient for transformation and broth mating assays.  
 
Antimicrobial susceptibility 
Antimicrobial drug susceptibilities were determined according to the guidelines of the CLSI by broth 
microdilution (Table S1, available as Supplementary data at JAC Online) and Etest (bioMérieux, 
Nürtingen, Germany).
10
 The MBL phenotype was confirmed with MBL-Etest and a combined disc 
diffusion test CDDT (KPC + MBL Confirm ID Kit; Alere GmbH, Cologne, Germany).  
 
Presence of carbapenem resistance genes 
Detection of OXA-type carbapenemases and associated insertion elements was performed by PCR 
and sequence analyses were performed as previously described.
11,12
 Detection of the blaNDM-1 gene 
was performed by PCR using primers ndm1_F (5′-CTGAGCACCGCATTAGCC-3′) and ndm-1_R (5′-
GGGCCGTATGAGTGATTGC-3′). For detection of other common blaOXA genes (blaOXA-1,2,9,10), the 
following primers were used: oxa1_ F (5′-TATCTACAGCAGCGCCAGTG-3′); oxa1_ R (5′-
TAAATTCGACCCCAAGTTTCC-3′); oxa2_ F (5′-GCAAGAAGGCACGCTAGAAC-3′); oxa2_ R (5′-
CAGCGTCCGAGTTGACTG-3′); oxa9_ F (5′-TTTGCTGCTGCATATGTTGG-3′); oxa9_ R (5′-




Strain typing was performed by rep-PCR using the DiversiLab system (bioMérieux) and results were 
compared with our database of worldwide clonal lineages.
9
 In addition, multiplex PCR-based typing in 




Characterization of blaNDM-1 
Transfer of β-lactam resistance was tested by broth mating assays with E. coli J53 as the recipient. 
Selection of transconjugants was performed on Mueller–Hinton agar plates that contained sodium 
azide (200 mg/L) and ampicillin (100 mg/L). Plasmid DNA was isolated using the QIAGEN Plasmid 
Mini Kit (QIAGEN, Hilden, Germany).  
Transformation of plasmids into an electrocompetent E. coli J53 and A. baumannii ATCC 19606 and 
ATCC 17978 recipients was performed using standard procedures.
14
 Plasmid size was determined by 
performing S1 nuclease restriction of whole genomic DNA combined with PFGE.
15
 Southern 
hybridization using digoxigenin-dUTP-labelled probes and signal detection using CDP-Star were 
performed following the manufacturer's guidelines (Roche Diagnostics Ltd, West Sussex, UK).  
Whole genomic DNA was isolated using the QIAGEN DNeasy kit and digested with EcoRV, ligated 




 Inserts of isolates that grew on ticarcillin were amplified by PCR using M13 primers and 
sequenced. Insert DNA was sequenced on both strands by primer walking.  
Additionally, transfer of naked whole genomic DNA of A. baumannii 161/07 into an ampicillin-
susceptible A. baumannii 102/07 recipient by natural transformation was performed. We have recently 
identified conditions promoting the uptake of naked DNA by a significant number of A. baumannii 
isolates. These results will be published elsewhere (E. Skiebe and G. Wilharm, unpublished results).  
 
Nucleotide sequence accession number 
The nucleotide and protein sequences of the blaNDM-1-containing transposon and gene aphA-6 have 
been registered in GenBank under accession numbers HQ857107 and JF949760, respectively.  
 
 
Results and discussion 
Strain typing by rep-PCR (DiversiLab) revealed that the NDM-1-producing multidrug-resistant A. 
baumannii strain 161/07 clustered with isolates of the clonal lineage WW7. Previous work has shown 
that A. baumannii strains belonging to the WW7 cluster harboured the carbapenemase genes blaOXA-58 
or blaOXA-23 and were from different countries in South America, Europe and Asia.
9
 Furthermore, all A. 
baumannii of the WW7 cluster harboured blaOXA-64, a variant of the intrinsic blaOXA-51.
17
 It was 
confirmed by PCR that A. baumannii 161/07 was positive for the chromosomally located blaOXA-64, but 
this gene was not associated with insertion element ISAbaI. Other blaOXA genes were not detected. 
PCR-based A. baumannii typing in combination with ApaI PFGE analysis confirmed that A. baumannii 
161/07 was not related to European clonal lineages 1–3.
13
 
Transfer of resistance genes by in vitro conjugation and transformation of plasmids into E. coli or A. 
baumannii recipients was not successful. Analysis of S1-digested DNA fragments revealed the 
presence of two plasmids (125 kb, 75 kb) in the NDM-1-producing A. baumannii 161/07 strain. 
However, hybridization signals with a blaNDM-1 probe were not detected for these plasmids, and PCR 
with blaNDM-1-specific primers failed to amplify a PCR product, suggesting a chromosomal location of 
blaNDM-1.  
Using naked whole genomic DNA from A. baumannii 161/07 to transform the naturally competent 
ampicillin-susceptible A. baumannii recipient 102/07, the gene blaNDM-1 was successfully transferred, 
as confirmed by PCR. All β-lactams tested against the transformant 161/07-102 showed an increase 
in MIC, with imipenem and meropenem MICs increasing from 0.25 mg/L to >32 mg/L, and 0.5 mg/L to 
32 mg/L, respectively (Table S1). No other class of antibiotic was affected.  
Sequence analysis of shotgun cloned A. baumannii 161/07 genomic DNA revealed a 3.9 kb insert 
containing the blaNDM-1 gene and parts of the plasmid sequence pKpANDM-1 described previously 
(Figure 1C).
3
 However, the IS26 transposase upstream of blaNDM-1 in previously characterized 
plasmids pKpANDM-1 and pNDM-HK was not present in A. baumannii 161/07. Instead, the insertion 
sequence ISAba125 was identified (Figure 1B). Interestingly, pKpANDM-1 includes a partial sequence 
of ISAba125 adjacent to blaNDM-1. BLAST analysis of ISAba125 revealed seven copies of ISAba125 on 
the chromosome of A. baumannii strain ACICU in the GenBank database, and ISAba125 was found 
disrupting the carO gene, leading to carbapenem resistance.
18
 Furthermore, ISAba125 can also be 
plasmid located, and has been described recently upstream of the blaOXA-58 gene.
19
  
To determine whether blaNDM-1 was located in a transposon, PCR was performed with inverse primers 
to ISAba125 [TRANSIS_R (5′-AAACAACGGATCGCTTCAAC-3′) and TRANSIS_F (5′-
CGAGCATTACCAAAGGGTGA-3′)] using genomic DNA of A. baumannii 161/07 as template. Two 
products of 2 kb and 9 kb were amplified. Sequencing of the 2 kb amplicon revealed aphA-6, an 
aminoglycoside resistance gene bracketed between two copies of ISAba125.  
Primer walking from both ends of the 9 kb amplicon revealed a composite transposon structure 
containing blaNDM-1 bracketed between two copies of ISAba125 (Figure 1B). Both copies of ISAba125 
  
were flanked by 17 bp inverted repeats. Both 5′ inverted repeats and both 3′ inverted repeats were 
identical, respectively, but there were two nucleotide differences between 5′ and 3′ inverted repeats. 
The two ISAba125 transposase genes differed by four nucleotides whereby one resulted in amino acid 
substitution, Arg-41→Gln. Including both ISAba125 insertion elements, the composite transposon was 
10 093 bp in length. Furthermore, it was integrated into a chromosomal gene encoding a putative A. 
baumannii major facilitator superfamily (MFS) metabolite/H
+
 symporter (Figure 1A) that has previously 
been disrupted by ISAba1-blaOXA-23.
20
 Further PCR and sequencing with primers for ISAba125 and the 
disrupted MFS transporter confirmed the chromosomal location of the blaNDM-1-containing transposon. 
Evidence of this being a transposition event was an 8 bp target site duplication at the point of insertion 
in the gene encoding MFS (Figure 1E). Adjacent to the MFS gene we identified a chromosomal 
homoserine lactone synthase gene (cepI). In addition, inside the blaNDM-1-containing transposon there 
was a 4 kb element 93% similar to that described in E. coli plasmids pEH4H and pAR060302, 
encoding the chaperonin subunits groS and groL, and the transposase insE, which was not associated 
with inverted repeats (Figure 1D). The 8 bp target site duplication was also present at the 5′-end of the 
insE gene (Figure 1E). Further BLAST analysis revealed a 297 bp sequence, including 41 bp of the 3′-
end of insE and extending towards ISAba125, that showed 99% identity to insertion sequence 
ISCR19-like and oriIS previously described in a Pseudomonas aeruginosa isolate.
21
 Deletions were 
found in gene trpF (79 bp, 3′-end) and gene groS (154 bp, 5′-end). No significant DNA homology or 
open reading frames were detected in the 1.6 kb region between the truncated trpF and groS genes.  
In conclusion, analysis of the genetic environment of blaNDM-1 in A. baumannii 161/07 revealed a 
transposon structure composed of two copies of insertion sequence ISAba125 that is integrated into 
the bacterial chromosome. However, since blaNDM-1 is flanked by these insertion elements, we cannot 
discount the possibility of integration into a plasmid and subsequent horizontal spread. The variability 
of the genetic environment of blaNDM-1, as evidenced by the transposon structure described here, with 
DNA seemingly originating from Enterobacteriaceae, P. aeruginosa and A. baumannii, may explain the 
observed rapid dissemination of this gene within many Gram-negative bacterial species and across 
genera. Thus there is an urgent need for further investigations to find the origin of this gene and its 
mechanisms of spread.  
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Figure 1. Schematic diagram showing the genetic environment of blaNDM-1 in A. baumannii 161/07. (A) 
Chromosomal genes cepI and the truncated mfs; (B) ISAba125; (C) blaNDM-1 and truncated trpF; (D) 
truncated chaperonin subunit groS, chaperonin groL and the transposase insE; (E) 8 bp target 
duplication.  
 
 
 
 
 
